Table 3.
Multivariate logistic regression analysis of independent factors associated with CAD
| Independent variable | β | S.E. | P | OR | 95% CI |
|---|---|---|---|---|---|
| Model 1 | |||||
| Gender (women) | –1.211 | 0.339 | < 0.001 | 0.298 | 0.153-0.579 |
| Age | 0.055 | 0.016 | 0.001 | 1.057 | 1.023-1.092 |
| Lipid-lowering therapy | 1.223 | 0.401 | 0.002 | 3.396 | 1.548-7.452 |
| 1,5-AG | –0.044 | 0.017 | 0.008 | 0.957 | 0.927-0.989 |
| Model 2 | |||||
| Gender (women) | –1.101 | 0.334 | 0.001 | 0.332 | 0.173-0.640 |
| Age | 0.056 | 0.017 | 0.001 | 1.058 | 1.024-1.092 |
| Lipid-lowering therapy | 1.246 | 0.401 | 0.002 | 3.476 | 1.584-7.627 |
| GA | 0.134 | 0.044 | 0.002 | 1.143 | 1.048-1.247 |
Model 1: traditional risk factors for CAD (gender, age, BMI, W, SBP, DBP, TC, TG, HDL-c, LDL-c, eGFR, CRP, HOMA-IR, FPG, 2hPG, smoking status, family history of CAD, hypoglycemic therapy, anti-hypertensive therapy, lipid-lowering therapy), HbA1c and 1,5-AG.
Model 2: traditional risk factors for CAD, HbA1c, 1,5-AG and GA.